GlobeNewswire by notified

Grant of warrants

Share


23 April 2024
Announcement no. 9

Grant of Warrants

COPENHAGEN, DENMARK and BOSTON, MA, USA, April 23, 2024 (GLOBE NEWSWIRE) – The Board of Directors of BioPorto A/S (“BioPorto” or the “Company”) (CPH:BIOPOR) has resolved, in accordance with the annual general meeting’s resolution on April 27, 2023, to issue a total of 4,000,000 warrants to members of the Executive Management.

Each warrant grants the holder the right to subscribe for one share in BioPorto. The exercise price is DKK 1.23 per share, corresponding to the closing price today on Nasdaq Copenhagen. The warrants are issued in accordance with section 18 a of the Articles of Association.

Half of the warrants vest over a 2-year period, and the remaining half upon completion of a qualified capital raise in the Company with terms of qualification (including timing and amount of proceeds) to be defined by the Board of Directors. The warrants are otherwise subject to the Company’s incentive warrant program as included in Appendix 1 of the Company’s Articles of Association. The warrants include conditions on claw-back in case of e.g., erroneous financial information and provisions on accelerated vesting in case of e.g., a takeover bid and/or business combinations.

Detailed terms of the new and existing warrants, including applicable vesting schedules and exercise periods, can be found in the Articles of Association on www.bioporto.com under Investor Relations> Governance> Company Articles.

The theoretical market value of the newly issued warrants is DKK 1,285,000. The calculation is based on the Black-Scholes formula using an interest rate of 3.19% and the historical volatility of BioPorto A/S’ shares over 11 months calculated to 66.44%.

To receive BioPorto’s Company Announcements, Press Releases, Newsletters and other business relevant information, please sign up on https://bioporto.com/investor-contact/.

For inquiries, please contact

Investor Relations

Claus Thestrup, HC Andersen Capital, +45 4529 0000, investor@bioporto.com

Ashley R. Robinson, LifeSci Advisors, +1 617 430 7577, arr@lifesciadvisors.com

About Acute Kidney Injury

Acute kidney injury is a sudden episode of kidney failure or kidney damage that happens within a few hours or a few days. AKI causes a build-up of waste products in blood and makes it difficult for kidneys to maintain the proper balance of bodily fluids. AKI can also affect other organs such as the brain, heart, and lungs and is common in patients who are in hospital intensive care units. For more information about AKI please visit: https://bioporto.com/aki/.

About BioPorto

BioPorto is an in vitro diagnostics company focused on saving lives and improving the quality of life with actionable biomarkers – tools designed to help clinicians make changes in patient management. The Company uses its expertise in antibodies and assay development, as well as its platform for assay development, to create a pipeline of novel and compelling products that focus on conditions where there is significant unmet medical need, and where the Company’s tests can help improve clinical and economic outcomes for patients, providers, and the healthcare ecosystem.

The Company’s flagship products are based on the NGAL biomarker and designed to aid in the risk assessment and diagnosis of Acute Kidney Injury, a common clinical syndrome that can have severe consequences, including significant morbidity and mortality, if not identified and treated early. With the aid of NGAL levels, physicians can identify patients potentially at risk of AKI more rapidly than is possible with current standard of care measurements, enabling earlier intervention and more tailored patient management strategies. The Company markets NGAL tests under applicable registrations including CE mark in several countries worldwide.

BioPorto has facilities in Copenhagen, Denmark and Boston, MA, USA. The shares of BioPorto A/S are listed on the Nasdaq Copenhagen stock exchange. For more information visit www.bioporto.com.


To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Udnævnelse af ny CFO24.5.2024 20:05:00 CEST | pressemeddelelse

MEDDELELSE NR. 269 Udnævnelse af ny CFO Bestyrelsen i ChemoMetec har med virkning fra 1. juli 2024 ansat Kim Nicolajsen som ny CFO. Kim Nicolajsen kommer fra en tilsvarende stilling som CFO i den familieejede virksomhed Rohde Nielsen. Han er statsautoriseret revisor og har tidligere arbejdet for KPMG og EY. Bestyrelsen har samtidig indgået aftale med selskabets nuværende CFO Niels Høy Nielsen om, at han fratræder sin stilling samtidig med Kim Nicolajsens tiltræden. Bestyrelsen vil gerne takke Niels Høy Nielsen for hans indsats i ChemoMetec og for det gode samarbejde. Direktionen i ChemoMetec vil herefter bestå af CEO Martin Helbo Behrens og CFO Kim Nicolajsen. Yderligere oplysninger Bestyrelsesformand Niels Thestrup Telefon: (+45) 3370 2000 CEO Martin Helbo Behrens Telefon: (+45) 4813 1020 Om ChemoMetec A/S ChemoMetec udvikler, producerer og markedsfører instrumenter til celletælling og en lang række andre målinger. ChemoMetecs instrumenter markedsføres globalt inden for blandt andet f

Appointment of new CFO24.5.2024 20:05:00 CEST | Press release

ANNOUNCEMENT NO. 269 Appointment of new CFO The board of ChemoMetec has appointed Kim Nicolajsen as new CFO with effect from 1 July 2024. Kim Nicolajsen comes from a similar position as CFO in the family-owned company Rohde Nielsen. He is state-authorized public accountant and has previously worked for KPMG and EY. The board has also entered into an agreement with the company's current CFO Niels Høy Nielsen that he will resign from his position at the same time as Kim Nicolajsen takes over. The board would like to thank Niels Høy Nielsen for his contribution to ChemoMetec and for the good cooperation. CEO Martin Helbo Behrens and CFO Kim Nicolajsen will hereafter form the executive management of ChemoMetec. For further information Chairman of the Board Niels Thestrup Phone: (+45) 3370 2000 CEO Martin Helbo Behrens Phone: (+45) 4813 1020 About ChemoMetec A/S ChemoMetec develops, manufactures and markets instruments for cell counting and a wide range of other measurements. ChemoMetec’s i

Interim Report January – March 202424.5.2024 19:35:00 CEST | Press release

First quarter 2024 (compared to first quarter 2023) Net sales for the quarter amounted to MSEK 13 (13)Gross margin for the quarter decreased to 67% (74%)Operating loss amounted to MSEK -14 (-14)Earnings per share before and after dilution decreased to SEK 0.00 (-0.12) The report for January – March 2024 is available in its entirety on the following address: https://www.anoto.com/investors/reports/ For further information contact: Kevin Adeson, Chairman of the Board of Directors For more information about Anoto, visit www.anoto.com or email ir@anoto.com Anoto Group AB (publ), Reg.No. 556532-3929, Flaggan 1165, 116 74 Stockholm This information constitutes inside information as Anoto Group AB (publ) is obliged to disclose under the EU Market Abuse Regulation 596/2014. The information was provided by the contact person above for publication on 24 May 2024 at 19:30 CEST. About Anoto Group Anoto is a publicly held Swedish technology company known globally for innovation in the area of infor

Delårsrapport för januari – mars 202424.5.2024 19:35:00 CEST | Pressemelding

Första kvartalet 2024 (jämfört med första kvartalet 2023) Nettoomsättningen uppgick till MSEK 13 (13)Bruttomarginalen minskade till 67 % (74 %)Rörelseförlusten uppgick till MSEK -14 (-14)Resultat per aktie före och efter utspädning uppgick till SEK 0.00 (-0.12) Delårsrapporten för januari-mars 2024 finns tillgänglig i dess helhet på följande adress: https://www.anoto.com/investors/reports/ För ytterligare information kontakta: Kevin Adeson, Styrelseordförande För mer information om Anoto, besök www.anoto.com eller email ir@anoto.com Anoto Group AB (publ), Org.nr 556532-3929, Flaggan 1165, 116 74 Stockholm Denna information är sådan information som Anoto Group AB (publ) är skyldigt att offentliggöra enligt EU:s marknadsmissbruksförordning. Informationen lämnades genom ovanstående kontaktpersons försorg för offentliggörande den 24 maj 2024, kl. 19:30 CEST. Om Anoto Anoto är ett börsnoterat svenskt teknikföretag, som är känt i hela världen för innovationer rörande informationsrika mönster

Production report for April 202424.5.2024 17:48:23 CEST | Press release

Oslo, 24 May 2024 March 2024April 2024OperatedBoepd (1)Bopd (1)Boepd (1)Bopd (2)Colombia 699492675458Argentina1,584270 1,903296Total operated2,283762 2,578754Total equity1,145436 1,267425 (1) Barrels of oil equivalents per day (includes liquid and gas) (2) Barrels of oil per day (represents only liquids) [boepd]: barrels of oil equivalents per day (includes liquid and gas) [Operated]: 100% field production operated by Interoil [Equity]: Interoil’s share production net of royalties. Comments Interoil’s total daily average operated production in April increased by 295 boepd compared with previous month. This increase is mainly coming from the Argentinean fields whereas Colombia once again experienced a slight reduction of flows. In Argentina, the operated production increased by 319 boepd, as the gas compressors have arrived allowing more gas flows especially from the Oceano Field in the Santa Cruz assets. The reopening pulling program in the Santa Cruz wells is still ongoing as programm

HiddenA line styled icon from Orion Icon Library.Eye